Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)
- PMID: 9639369
Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)
Abstract
These revised recommendations of the Advisory Committee on Immunization Practices (ACIP) on measles, mumps, and rubella prevention supersede recommendations published in 1989 and 1990. This statement summarizes the goals and current strategies for measles, rubella, and congenital rubella syndrome (CRS) elimination and for mumps reduction in the United States. Changes from previous recommendations include: Emphasis on the use of combined MMR vaccine for most indications; A change in the recommended age for routine vaccination to 12-15 months for the first dose of MMR, and to 4-6 years for the second dose of MMR; A recommendation that all states take immediate steps to implement a two dose MMR requirement for school entry and any additional measures needed to ensure that all school-aged children are vaccinated with two doses of MMR by 2001; A clarification of the role of serologic screening to determine immunity; A change in the criteria for determining acceptable evidence of rubella immunity; A recommendation that all persons who work in health-care facilities have acceptable evidence of measles and rubella immunity; Changes in the recommended interval between administration of immune globulin and measles vaccination; and Updated information on adverse events and contraindications, particularly for persons with severe HIV infection, persons with a history of egg allergy or gelatin allergy, persons with a history of thrombocytopenia, and persons receiving steroid therapy.
Similar articles
-
Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34. MMWR Recomm Rep. 2013. PMID: 23760231
-
Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12. MMWR Recomm Rep. 2010. PMID: 20448530
-
Rubella prevention. Recommendations of the Immunization Practices Advisory Committee (ACIP).MMWR Recomm Rep. 1990 Nov 23;39(RR-15):1-18. MMWR Recomm Rep. 1990. PMID: 2174498
-
The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles.Dev Biol Stand. 1986;65:45-52. Dev Biol Stand. 1986. PMID: 3104117 Review.
-
Two doses of MMR vaccine--sufficient to eradicate measles, mumps and rubella?Scand J Soc Med. 1988;16(3):129-35. doi: 10.1177/140349488801600301. Scand J Soc Med. 1988. PMID: 3057621 Review.
Cited by
-
Epidemiology of mumps, mumps complications, and mumps orchitis in Korea using the National Health Insurance Service database.Investig Clin Urol. 2023 Jul;64(4):412-417. doi: 10.4111/icu.20230064. Investig Clin Urol. 2023. PMID: 37417567 Free PMC article.
-
Prevention of measles, mumps and rubella: 40 years of global experience with M-M-RII.Hum Vaccin Immunother. 2021 Dec 2;17(12):5372-5383. doi: 10.1080/21645515.2021.2007710. Epub 2022 Feb 7. Hum Vaccin Immunother. 2021. PMID: 35130794 Free PMC article.
-
[Vaccinations for pregnant women and women attempting to become pregnant].Gynakol Endokrinol. 2022;20(2):93-100. doi: 10.1007/s10304-022-00439-5. Epub 2022 Feb 1. Gynakol Endokrinol. 2022. PMID: 35125986 Free PMC article. Review. German.
-
Efficacy of an inactivated Zika vaccine against virus infection during pregnancy in mice and marmosets.NPJ Vaccines. 2022 Jan 27;7(1):9. doi: 10.1038/s41541-021-00426-0. NPJ Vaccines. 2022. PMID: 35087081 Free PMC article.
-
Seroepidemiology of Measles, Mumps, Rubella and Varicella in Italian Female School Workers: A Cross-Sectional Study.Vaccines (Basel). 2021 Oct 16;9(10):1191. doi: 10.3390/vaccines9101191. Vaccines (Basel). 2021. PMID: 34696299 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical